Mersana Therapeutics, Inc. Current Assets
Mersana Therapeutics, Inc. had Current Assets of $59.99 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2025-11-14
- 2025-09-30: Assets, Current $59.99M.
- 2025-06-30: Assets, Current $80.14M.
- 2025-03-31: Assets, Current $106.19M.
- 2024-12-31: Assets, Current $136.90M.
| Period end | Assets, Current |
|---|---|
| 2025-09-30 | $59.99M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $80.14M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $106.19M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $136.90M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $160.56M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $168.96M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $187.54M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $214.06M 10-K · filed 2025-03-03 |
| 2023-09-30 | $249.74M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $297.09M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $281.81M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $319.22M 10-K · filed 2024-02-28 |
| 2022-09-30 | $300.04M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $237.08M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $241.47M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $188.90M 10-K · filed 2023-02-28 |
| 2021-09-30 | $199.36M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $233.43M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $231.95M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $258.58M 10-K · filed 2022-02-28 |
| 2020-09-30 | $274.93M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $294.90M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $80.29M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $101.33M 10-K · filed 2021-02-26 |
| 2019-09-30 | $114.70M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $131.62M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $141.07M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $74.31M 10-K · filed 2020-02-28 |
| 2018-09-30 | $90.05M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $102.19M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $111.36M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $117.54M 10-K · filed 2019-03-08 |
| 2017-09-30 | $136.72M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $79.56M 10-Q · filed 2017-08-11 |
| 2016-12-31 | $102.17M 10-K · filed 2018-03-28 |